null

Dupilumab Biosimilar (Anti-IL-4RA) Antibody (HDBS0051)

SKU:
HDBS0051
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
IL-4RA
Reactivity:
Human
Host Species:
Chimeric Humanized
Isotype:
IgG4
€399

Description

system_update_altDatasheet

Dupilumab (Anti-IL-4RA) Biosimilar Antibody (HDBS0051)

The Anti-IL-4RA (Dupilumab Biosimilar) Antibody (HDBS0051) is a cutting-edge research tool designed for studying the interleukin-4 receptor alpha (IL-4RA), a key component in the IL-4 signaling pathway. This monoclonal antibody, developed through advanced technology, specifically targets IL-4RA and is highly sensitive in detecting this protein in human samples.IL-4RA is a crucial receptor involved in immune responses and inflammatory processes, making it a promising target for therapeutic interventions in conditions such as allergic diseases, asthma, and autoimmune disorders.

By blocking the interaction between IL-4 and its receptor, this antibody can provide insights into the mechanisms underlying these diseases and aid in the development of novel treatment options.With its high specificity and sensitivity, the Anti-IL-4RA (Dupilumab Biosimilar) Antibody (HDBS0051) is a valuable tool for researchers in immunology, pharmacology, and drug development. Its ability to target IL-4RA opens up new possibilities for studying immune regulation and developing targeted therapies for a range of inflammatory conditions.